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Background: Chronic kidney disease (CKD) is a growing public health problem and end stage renal disease (ESRD)
represents a large human and economic burden. It is important to identify patients at high risk of ESRD. In order to
determine whether renal Doppler resistive index (RI) may discriminate those patients, we analyzed whether RI was
associated with identified prognosis factors of CKD, in particular histological findings, and with renal outcome.
Methods: RI was measured in the 48 hours before renal biopsy in 58 CKD patients. Clinical and biological data
were collected prospectively at inclusion. Arteriosclerosis, interstitial fibrosis and glomerulosclerosis were
quantitatively assessed on renal biopsy in a blinded fashion. MDRD eGFR at 18 months was collected for 35 (60%)
patients. Renal function decline was defined as a decrease in eGFR from baseline of at least 5 mL/min/ 1.73 m2/year
or need for chronic renal replacement therapy. Pearson’s correlation, Mann–Whitney and Chi-square tests were
used for analysis of quantitative and qualitative variables respectively. Kaplan Meier analysis was realized to
determine renal survival according to RI value using the log-rank test. Multiple logistic regression was performed
including variables with p < 0.20 in univariate analysis.
Results: Most patients had glomerulonephritis (82%). Median age was 46 years [21–87], eGFR 59 mL/min/
1.73m2 [5–130], percentage of interstitial fibrosis 10% [0–90], glomerulosclerosis 13% [0–96] and RI 0.63 [0.31-1.00].
RI increased with age (r = 0.435, p = 0.0063), pulse pressure (r = 0.303, p = 0.022), renal atrophy (r = −0.275, p =
0.038) and renal dysfunction (r = −0.402, p = 0.0018). Patients with arterial intima/media ratio ≥ 1 (p = 0.032),
interstitial fibrosis > 20% (p = 0.014) and renal function decline (p = 0.0023) had higher RI. Patients with baseline RI
≥ 0.65 had a poorer renal outcome than those with baseline RI < 0.65 (p = 0.0005). In multiple logistic regression,
RI≥0.65 was associated with accelerated renal function decline independently of baseline eGFR and proteinuria/
creatininuria ratio (OR=13.04 [1.984-85.727], p = 0.0075). Sensitivity, specificity, predictive positive and predictive
negative values of RI ≥ 0.65 for renal function decline at 18 months were respectively 77%, 86%, 71% and 82%.
Conclusions: Our results suggest that RI ≥ 0.65 is associated with severe interstitial fibrosis and arteriosclerosis and
renal function decline. Thus, RI may contribute to identify patients at high risk of ESRD who may benefit from
nephroprotective treatments.
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Chronic kidney diseases (CKD) represent a growing pub-
lic health problem [1]. Only few patients will experi-
enced rapid renal function decline [2] and fewer will
reach end stage renal disease [3]. Prediction of renal
function outcome is a critical issue. Predictive factors in-
clude arterial hypertension, proteinuria and baseline
renal function. In addition, interstitial fibrosis closely
correlates to renal function and long-term prognosis [4]
but in most patients, renal histology assessment is not
performed. We interested in renal arterial resistive index
(RI) because it can be measured not invasively by
Doppler analysis of intrarenal arterial blood flow veloci-
ties and because its prognosis value has been proven
in various clinical settings. These include the thera-
peutic management of renal artery stenosis [5,6]. Dur-
ing renal transplantation, increase in RI early after
surgery is a marker of tubular necrosis [7] and, later on,
is predictive of long-term graft dysfunction [8].
However, the clinical interest of RI in the course of
CKD is still unclear. Twenty years ago, Platt et al.
showed that RI was significantly higher in nephropathies
with tubulo-interstitial and/or vascular injury than in
isolated glomerulopathies. Later on, four studies ana-
lyzed the correlation between RI and histological
changes associated with the progression of CKD [9-12].
However, several points make these results questionable.
First of all, pathological criteria were not clearly defined
in two of these studies [10,11]. Moreover, although
authors agreed that RI increased with tubulo-interstitial
injury, three studies [10-12] did not distinguish chronic
lesions, such as tubular atrophy and interstitial fibrosis,
from interstitial oedema and cellular infiltration, which
may result from acute injury. Three studies tested the
correlation between RI and glomerulosclerosis and
found conflicting results [9,10,12]. Only two groups
examined simultaneously the association of RI with vari-
ous lesions associated with CKD, i.e. tubulo-interstitial,
glomerular and vascular lesions. Whereas the first study
showed an association of RI with arteriosclerosis, but
not with arteriolosclerosis [10], the most recent one
found that vascular lesions were globally associated with
RI without distinction between arteriolar and arterial
lesions [9]. Furthermore, the most accurate threshold of
RI in clinical practice is still debated [12,13]. In parallel,
several studies reported the correlation of RI with renal
outcome in CKD [9,11,13-17].
Despite these encouraging results, renal Doppler
remains underemployed for the management of CKD in
clinical practice. We conducted a prospective study in
patients who underwent renal biopsy for diagnosis of
CKD. Our primary goal was to assess the association be-
tween pathological lesions and RI. The second objective
was to determine the relation of RI with renal functionoutcome. The last purpose was to establish the most
relevant threshold of RI in clinical practice.
Methods
Ethics statement
The study was approved by the ethic committee CPP
Ile-de France 5 and written informed consent was
obtained from all participants.
Patients
We carried out a prospective study from October 2006
to November 2007 in 58 consecutive patients referred to
the Nephrology department of the Tenon Hospital in
Paris, France, who underwent a diagnosis renal biopsy.
Inclusion criteria were the following: i) existence of a
chronic kidney disease according to the KDOQI defin-
ition [18], i.e. estimated glomerular filtration rate (eGFR)
< 60 mL/min/ 1.73 m2 and/or albuminuria ii) presence
of at least 5 glomeruli on the biopsy sample, iii) renal
US Doppler performed within two days before renal bi-
opsy with a standardized measurement of RI. Patients
were excluded from the study if they had renal artery
stenosis, acute cardiac failure or hepato-renal syndrome.
Clinical and biological data
Clinical (age, sex, treatments and blood pressure) and bio-
logical data (serum creatinine, eGFR according to the
modified MDRD formula and proteinuria/creatininuria
ratio) were collected prospectively at inclusion. Biochemical
parameters were all measured in the biochemistry labora-
tory of the hospital.
MDRD eGFR at 6, 12 and 18 months after renal biopsy
was collected in 46 (79%), 43 (74%) and 35 (60%) patients,
respectively. In cohort studies, slope of eGFR decline is
less than -5 mL/min/ 1.73 m2 in the majority of CKD
patients [2,19-23]. In order to be close to clinical practice,
we chose to define renal function decline as a decrease in
eGFR of at least 5 mL/min/ 1.73 m2/year from baseline
or need for chronic renal replacement therapy (RRT).
Ultrasonographic doppler examination
US Doppler examination was performed in a standar-
dized fashion by one of the two well-trained ultrasono-
graphers selected for the study, in fasted patients. A
SIEMENS ELEGRA SS device and a 3.5 MHz probe
were used. For each patient, the maximal length of both
kidneys was measured and added to obtain combined
renal length. Arterial velocity signals were obtained from
segmental or interlobar arteries in one kidney. Three
records were performed at superior, medium and infer-
ior poles. RI was calculated according to the Pourcelot’s
formula: [(peak systolic velocity- end diastolic velocity)/
peak systolic velocity]. The mean of the three poles mea-
sures was used as the reference value of RI for each
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with a Pearson’s correlation coefficient > 0.99.
Histological examination
For each patient, histological analysis was performed by a
unique senior pathologist who was unaware of US Doppler
results. Light microscopy examination was performed on
samples stained by H & E, PAS, Jones and Masson’s tri-
chrome. The whole cortex was analyzed on eight serial sec-
tions of each biopsy under 25 to 400 × magnification.
Interstitial fibrosis was assessed visually as the percentage
of fibrotic interstitial cortical tissue visible on Masson’s
stain by 5%-stages [24]. Glomerulosclerosis was defined as
the percentage of totally sclerotic glomeruli. Arteriolo-
sclerosis was defined as the presence of hyaline deposits in
the wall of at least one preglomerular arteriole (Figure 1A).
Absence of arteriolosclerosis was asserted when none of
the eight sections display hyaline deposits. Arteriosclerosis
was defined as a thickening of the intima of at least one ar-
tery. Patients were classified in three groups according to
the maximal intima thickness visible on the biopsy sample
(Figure 1B): i) absence of arteriosclerosis: normal intima
thickness, ii) moderate arteriosclerosis: thickening of intima
with an intima/media ratio < 1, iii) severe arteriosclerosis:
thickening of intima with an intima/media ratio ≥ 1.
Statistical analysis
Number and percentage of patients, median and
minimum-maximum values are provided for qualitative
and quantitative values respectively. Linear relationship of
RI with other variables was tested with Pearson’s correl-
ation test. Analysis of parameters associated with RI and
renal function decline were compared with Chi-square
and Mann–Whitney tests respectively for qualitative andFigure 1 Vascular lesions analyzed on renal biopsy (optic microscopy
the presence of hyaline deposits (arrow) in the wall of at least one arteriole
intima thickness visible on the sample biopsy was measured (double arrow
severe arteriosclerosis.quantitative variables. Kaplan Meier analysis was realized
to determine renal survival according to RI value using
the log-rank test. In order to determine independent para-
meters associated with RI or renal function decline, we
performed a multiple linear or logistic regression, respect-
ively, including variables with p < 0.20 in univariate
analysis.
Statistical analysis was performed using http://marne.
u707.jussieu.fr/biostatgv/ website, GraphPad Prism 5.0 and
StatView 5.0 softwares. A two-tailed p value < 0.05 was
considered to be significant.
Results
Characteristics of patients
Fifty-eight patients were enrolled in the study accord-
ing to the inclusion criteria. Their characteristics are
summarized in Table 1. They were predominantly male
(68.9%). Their median age was 49 years [23–89]. Their
median eGFR and proteinuria/creatininuria ratio were
respectively 59 mL/min/ 1.73 m2 [5–130] and 245 mg/
mmol [7–2000]. Forty seven (81%) patients presented
glomerular nephropathy. On biopsy, median sclerotic
glomeruli and interstitial fibrosis percentage were re-
spectively 13% [0–96] and 10% [0–90]. The presence of
arteriolosclerosis or arteriosclerosis could not be stud-
ied in 5 and 12 patients, respectively, because of the
absence of visible arteriole or artery on biopsy sample.
Hyaline arterial deposits were observed on 25 of the 53
biopsies with visible arteriolar sections (47.2%). Arterio-
sclerosis was observed in 21 of the 46 patients (45.6%)
for whom at least one artery was present on the bi-
opsy. Eight (17.3%) patients had severe arteriosclerosis
with an intima/media ratio ≥ 1 (Table 1). Median RI
was 0.62 [0.31 – 1.0]., Masson’s trichromic staining). A: Arteriolosclerosis was defined as
. B: Arteriosclerosis was defined as a thickening of intima. Maximal
). Here, intima/media ratio was superior to 1, which corresponds to
Table 1 Characteristics of patients at baseline






Pulse pressure 50 (28–80)
Renal function
Serum creatinine (μmol/L) 124 (54–906)
eGFR (ml/min/1,73m2) 59 (5–130)
Proteinuria/creatininuria(mg/mmol) 245 (7–2000)
Antihypertensive treatments
No antihypertensive drug 27 (46.5%)
1 antihypertensive drug 11 (19%)
2 antihypertensive drugs 9 (15.5%)
≥ 3 antihypertensive drugs 11 (19%)
RAS blockers 23 (39.6%)
Renal biopsy
% sclerotic glomeruli 13 (0–96)
% interstitial fibrosis 10 (0–90)
Vascular lesions 34/51 (66.7%)
Arteriolar hyaline deposits 25/53 (47.2%)
Intima/media ratio
Normal 25 (54.4%)
< 1 13 (28.3%)
≥ 1 8 (17.3%)
Diagnosis
FSGN/HIVAN 9 (15.5%)
IgA nephropathy 11 (19%)
Membranous nephropathy 7 (12.1%)
Minimal change disease 3 (5.2%)
Lupus 3 (5.2%)
Vascularitis 3 (5.2%)
Membranous proliferative nephritis 2 (3.4%)
Diabetes 2 (3.4%)
Amyloidosis 2 (3.4%)
Other glomerulonephritis 5 (8.6%)
Acute tubulo-interstitial nephritis 3 (1.7%)
Chronic tubulo-interstitial nephritis 2 (3.4%)
Vascular nephropathy 2 (3.4%)
Other 4 (6.9%)
Renal arterial resistive index 0.62 (0.31-1.00)
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arterial resistive index
We found a positive correlation between RI and age (r =
0.435, p = 0.0063), pulse pressure (r = 0.303, p = 0.022)
which are both associated with elevated arterial stiffness.Furthermore, RI was inversely correlated with baseline
eGFR (r = −0.402, p = 0.0018) and to a lesser extent with
combined renal length (r = −0.275, p = 0.038). In a mul-
tiple linear regression analysis including age, baseline
eGFR, pulse pressure and combined renal length, only
age (p = 0.0052) and baseline eGFR (p = 0.015) were in-
dependently associated with RI. We did not find any sig-
nificant correlation of RI with proteinuria/creatininuria
ratio (r = 0.141, p = 0.29), systolic (r = 0.080, p = 0.55)
and diastolic blood pressure (r = −0.169, p = 0.21). RI
was not different between patients who received an anti-
hypertensive treatment and those who did not (p =
0.89). In the same way, RI did not differ between
patients treated with renin angiotensin system (RAS)
blockers (p = 0.65) and those who were not. RI was not
influenced by the number of antihypertensive drugs pre-
scribed (p = 0.87).
Histological parameters associated with renal arterial
resistive index
RI was not different whether hyaline deposits were present
or not (0.62 [0.31-1.00] vs 0.63 [0.50-0.71], p = 0.99)
(Figure 2A). RI value was similar in patients with normal
intima or moderate intima thickening (intima/media ratio
< 1) (0.62 [0.52-0.83] vs 0.60 [0.31-0.69], p = 0.71). In con-
trast, patients with severe arteriosclerosis (intima/media
ratio ≥ 1) had a significantly higher RI than those with no
or moderate arteriosclerosis (0.73 [0.56-1.00] vs 0.61
[0.31-0.83], p = 0.032) (Figure 2B). No association was
found between RI value and glomerulosclerosis. RI tended
to increase with the percentage of interstitial fibrosis (n =
58, r = 0.222, p = 0.10) and was significantly higher when
interstitial fibrosis exceeded 20% (0.67 [0.55-1.00] vs 0.61
[0.31- 0.83], p = 0.014) (Figure 2C). Finally, patients with
isolated glomerular involvement had significant lower RI
than those with interstitial fibrosis > 5% and/or vascular
lesions (hyaline arterial deposits and/or intima thickening)
(0.60 [0.47-0.64] vs 0.64 [0.31-1.00], p = 0.05).
Association of renal arterial resistive index with renal
function outcome
Renal function outcome was assessed at 18 months in
35 (60%) patients (Table 2). Among them, 13 (37%)
patients experienced renal function decline. Seven
patients had a decrease in eGFR of at least 5 mL/min/
1.73 m2/year and 6 needed chronic RRT. Their RI was
significantly higher than RI of patients with stable or
improved renal function (0.69 [0.63-1.00] vs 0.61 [0.31-
0.70], p = 0.0023) (Table 2). In univariate analysis,
other factors associated with renal function decline at
18 months were: age (p = 0.0035), baseline eGFR (p =
0.052) and proteinuria/creatininuria ratio (p = 0.049)
(Table 2). Baseline RI ≥ 0.65 (p = 0.0075) and age (p =
0.037) were the only independent factors associated
Figure 2 Association of RI with histological parameters. Boxes
show the first and third quartiles, with the median as a thick line.
Whiskers extend to minimum and maximum values. A: RI according
to arteriolosclerosis, defined as the presence of hyaline deposits in
the wall of at least one preglomerular arteriole. B: RI according to
maximal intima thickness (moderate arteriosclerosis was defined as a
thickening of intima with intima/media ratio < 1 and severe
arteriosclerosis as an intima/media ratio ≥ 1). * p<0.05 versus normal
and intima/media<1. C: RI according to interstitial fibrosis. * p<0.05
versus interstitial fibrosis<20%.
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multiple logistic regression (Table 3).
Which RI threshold should be used in clinical practice?
In order to define the most accurate threshold, we draw
receiver operating characteristic (ROC) curves (Figure 3).
According to the ROC curves analysis, 0.65 thresholdwas the most discriminant for renal function decline at
18 months, interstitial fibrosis exceeding 20% and severe
arteriosclerosis. Analysis of renal survival using Kaplan-
Meier curves confirmed that patients with baseline RI ≥
0.65 had a poorer renal outcome than those with base-
line RI < 0.65 (p = 0.0005, Log-Rank test) (Figure 4).
Sensitivity, specificity, predictive positive and predictive
negative values of RI ≥ 0.65 for renal function decline at
18 months were respectively 77%, 86%, 71% and 82%.
Discussion
The present study shows that initial measurement of RI
in patients with various nephropathies at time of renal
biopsy is clinically relevant for several reasons. We show
that RI is associated with renal function and pulse pres-
sure, a surrogate marker of arterial stiffness. More im-
portantly, RI is associated with severe interstitial fibrosis
and arteriosclerosis and eGFR decline. Previous studies
reported either the association of RI with interstitial fi-
brosis, tubulo-interstitial lesions [9-12,25], or vascular
lesions [9-11] or renal outcome in CKD [9,11,13,15,16].
To our knowledge, none of these studies simultaneously
evaluated the association of RI with the main chronic
renal histological lesions and with renal function out-
come. Furthermore, the most relevant threshold of RI
for clinical practice was still debated. Here, the cut-off
value of 0.65 was the most discriminant for severe ar-
teriosclerosis, extended fibrosis and renal function
decline.
In this study, we analyzed the association of RI with
pathological changes and renal function outcome in an
unselected population of 58 patients with various
nephropathies and renal function alterations. In order to
be closer to clinical practice, our inclusion criteria differ
from other studies which were done in specific renal dis-
eases [12,25]. Our results emphasize the general predict-
ive value of RI in CKD patients independently of the
type of nephropathy. Secondly, only well-defined chronic
renal lesions as interstitial fibrosis, percentage of scler-
otic glomeruli, arteriosclerosis lesions were taken into
account in our study. These criteria differ from previous
studies which used combined scores as tubulo-
interstitial injury or interstitial fibrosis/tubular atrophy,
which could reflect acute kidney injury [9-12]. Despite a
relative small population of CKD patients, we found a
significant association of RI with severe renal lesions and
renal function decline, consistently with previous studies
[9-16,20].
As previous authors, we found a positive correlation
between RI and age [10,26-29] and in a lesser extent
with pulse pressure [26,30-33]. Prior studies reported an
association between RI and other markers of arterial
stiffness as pulse wave velocity [31,34] and ankle-
brachial blood pressure index [35]. In our study, RI was
Table 2 Univariate analysis of parameters associated with renal function decline at 18 months (defined as a decrease
in eGFR of at least 5 mL/min/ 1.73 m2/year or need for RRT) (Mann–Whitney and Fisher’s exact tests)
No decline Decline p
Number (%) of patients 22 (63%) 13 (37%)
Age (years) 38 (23–68) 55 (24–79) 0.0035
Baseline eGFR (mL/min/1.73m2) 65 (17–108) 12 (4–65) 0.052
eGFR(mL/min/1.73m2) at 18 months 69 (24–123) 8 (5–70) 0.000015
SBP (mmHg) 127 (98–160) 129 (98–163) 0.30
DBP (mmHg) 77 (62–91) 70 (59–96) 0.89
Proteinuria/creatininuria (mg/mmol) 96 (7–1216) 492 (69–1742) 0.049
% sclerotic glomeruli 16 (0–71) 4 (0–80) 0.88
% interstitial fibrosis 18 (0–80) 18 (0–90) 0.76
RI 0.61 (0.31-0.70) 0.69 (0.63-1.00) 0.0023
Number (%) of patients with RI ≥ 0.65 4 (18%) 10 (77%) 0.0011
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pressure despite its relationship with pulse pressure.
This suggests that the elevation of RI rather reflects the
vascular consequences of hypertension than hyperten-
sion itself. An alternative explanation is the lack of
power of our study. Nevertheless, this result was demon-
strated by previous authors who showed that RI is a
marker of target organ damage in essential hypertension
[30,32,34,36,37] as left ventricular hypertrophy, carotid
and coronary atherosclerosis. Other studies demon-
strated that high RI was also associated with systemic
atherosclerosis in diabetic patients [31,38] and renal
transplant recipients [35]. Moreover, Pearce et al. re-
cently showed that elevated renal RI is predictive of car-
diovascular events in the elderly [39].
The elevation of RI with severe arteriosclerosis may
account for its association with cardiovascular risk. As
previous authors [9,25], we actually found an association
between RI and renal arteriosclerosis. It is interesting to
note that only patients with severe intima thickening
exhibited high RI. Nor hyaline arteriolar deposits nor
moderate intima thickening were associated with
increased RI. This could be due to the lack of power ofTable 3 Multivariate analysis of parameters associated
with renal function decline at 18 months (defined as a
decrease in eGFR of at least 5 mL/min/ 1.73 m2/year or
need for RRT) (logistic regression, n=35 patients)
OR 95% CI P
Proteinuria/creatininuria (mg/mmol) 1.001 0.998-1.003 0.56
Baseline eGFR (mL/min/1.73m2) 0.977 0.936-1.021 0.30
Age (years) 1.079 0.996-1.169 0.062
RI ≥ 0.65 7.751 1.045-57.479 0.045
OR 95% CI P
Age (years) 1.078 1.004-1.158 0.037
RI ≥ 0.65 13.04 1.984-85.727 0.0075our study. Nevertheless, it could also suggest that the
presence of moderate vascular lesions is not sufficient to
induce an elevation of RI and that these alterations must
be important enough to reduce artery lumen, raise arter-
ial stiffness and vascular resistance, and consequently
generate an increase in RI. Overall, these findings sug-
gest that high RI reflects severe renal arteriosclerosis
and maybe systemic arteriosclerosis.
Our study also questioned the correlation of RI with
renal fibrosis. We did not find any relationship between
RI and glomerulosclerosis. Moreover, RI was significantly
lower in case of isolated glomerular involvement, i.e.
without any vascular and/or tubulo-interstitial damage.
This result corroborates previous findings of Platt et al.
[25]. Only one among three previous studies found a sig-
nificant association between glomerulosclerosis and RI
[10]. This correlation was weak in a second study [12]
and not significant in a multivariate analysis in the third
one [9]. Altogether, these findings suggest that glomeru-
losclerosis does not influence the value of RI.
On the other hand, as other authors, we found an asso-
ciation between RI value and the extension of interstitial
fibrosis [9,11,12,25] and the severity of renal impairment
[13,26,40-44]. Median percentage of interstitial fibrosis
was six fold higher in patients with RI exceeding 0.65. As
arteriosclerosis, interstitial fibrosis appears as an import-
ant determinant of RI. Three hypotheses can be drawn
about the physiopathological mechanisms involved in ele-
vation of RI with the progression of CKD: i) decrease in
arterial compliance and increase in vascular resistance be-
cause of renal arteriosclerosis, ii) elevation of pressure
exerted by interstitial fibrosis on adjacent vessels, iii) vaso-
constriction secondary to the hypoxia induced by the pre-
vious phenomena and by the loss of capillaries associated
with renal fibrosis. These mechanisms are probably com-
bined and our results do not allow us to precise which
one contributes the most to the elevation of RI.
Figure 3 Receiver operating characteristic (ROC) curves for RI
to discriminate. A: renal function decline at 18 months (AUC = 0.809,
p = 0.0002). B: interstitial fibrosis > 20% (AUC = 0.690, p = 0.037).
C: severe arteriosclerosis (AUC = 0.740, p = 0.039).
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was independently associated with accelerated renal
function decline. Sugiura et al. [13] reported similar re-
sult in a larger cohort of 311 CKD patients followed-up
for two years. Such results were also found by other
authors in CKD [11,14-17], essential hypertension [17]
and renal transplantation [8,45]. Our results extend pre-
vious findings to a population of patients with various
nephropathies. The concomitant association of RI with
interstitial fibrosis and arteriosclerosis which are known
to be major determinants of the progression of CKD [4]
may explain its prognosis value.
Finally, we attempted to define the most relevant thresh-
old of RI in clinical practice. Consistently with the first
findings of Sugiura et al. [12], we found that 0.65 was the
most accurate threshold to detect extent interstitial fibro-
sis, but also severe arteriosclerosis. Nevertheless, more re-
cently, Sugiura et al. suggested that 0.70 threshold was
better than 0.65 cut-off to predict renal function decline
[13]. In contrast, we found by ROC curves analysis that RI
≥ 0.65 has the best sensitivity (77%) and specificity (86%)
to discriminate renal function decline. This discrepancy
may be explained by the different definitions of renal func-
tion decline used in the two studies. Using the criteria of
at least 10 mL/min/ 1.73 m2/year, Sugiura et al. may have
selected more severe patients. In cohort studies, mean
slope of eGFR decline is less than 5 mL/min/ 1.73 m2 in
most CKD patients [2,19-23]. A decrease of 5 mL/min/
1.73 m2/year appears to be closer to clinical practice and
more helpful to detect a larger of number patients at high
risk of accelerated CKD progression.
Our study has several limits. We mostly included glom-
erulonephritis and few vascular and tubulo-interstitial dis-
eases. Because of the weak proportion of chronic vascular
and tubulo-interstitial diseases, we can wonder whether
our results could apply to those nephropathies. Never-
theless, several previous studies found an association
between high RI and poor renal outcome in essential
hypertension and chronic tubulo-interstitial nephropa-
thies [13,14,17,34,37]. The main limit of our study is
the non exhaustive collection of renal function data.
However, our results corroborate those of several pre-
vious studies [9,11,13,15,16].Conclusion
Our results show that RI ≥ 0.65 in CKD patients with
various nephropathies is associated with extended inter-
stitial fibrosis, severe arteriosclerosis and renal function
Figure 4 Kaplan Meier curves of renal survival according to baseline RI. Renal function decline is defined as decrease in eGFR of at least
5mL/min/1.73m2/year or need for RRT. Plain line represents patients with RI < 0.65 and dotted line those with RI ≥ 0.65; p = 0.0005,
log-rank test.
Bigé et al. BMC Nephrology 2012, 13:139 Page 8 of 9
http://www.biomedcentral.com/1471-2369/13/139decline. Consistently with previous findings, these results
suggest that non invasive US Doppler measurement of RI
could give the opportunity to identify CKD patients at
high risk of ESRD and help clinicians in their manage-
ment. Our results need to be confirmed in a larger tar-
geted intervention multicentric study of outpatients.
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